Drug intelligence / Profile preview

ACH-15

Development stage: Unknown
Lead developer: Ache Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

ACH-15 is a small molecule drug candidate that was initially developed by Aché Laboratórios Farmacêuticos. Its mechanism of action is unknown, and it was being investigated for unspecified indications in the therapeutic area of "Other Diseases." The drug reached a global highest R&D status of "Discontinued," indicating that its development has ceased and it is not available on the market. It was intended for oral administration.

Beyond the preview

Go deeper on ACH-15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACH-15.

Explore the full profile